Public Health
WHO recommends its first malaria vaccine
A malaria vaccine developed by GlaxoSmithKline, Mosquirix, has been recommended for use by the World Health Organization.
A malaria antibody prevented infections in purposefully-infected volunteers
In a small study, researchers found an antibody that prevents malaria infection in people purposefully infected with the parasite.
Want better nasal vaccines? Look to the bacteria in your nose.
Researchers are investigating the link between the bacteria inside your nose and how effective nasal vaccines can be.
FDA approves COVID-19 boosters for seniors, high-risk groups (Updated)
The FDA has expanded its authorization of COVID-19 boosters of Pfizer’s vaccine to include seniors and people in high-risk populations.
Pfizer says its COVID-19 vaccine works in kids
New trial results suggest Pfizer’s COVID-19 vaccine works in kids between the ages of 5 and 11, safely triggering a robust antibody response.
How we doubled our life expectancy in the last 100 years
“The idea of taking a pill and getting better is actually a very recent invention.”
Study: COVID-19 booster shots dramatically reduce infection risk
A large COVID-19 booster shot study in Israel found that a third dose significantly increased seniors’ protection against the coronavirus.
UK researchers are growing the Delta variant for human challenge trials
Responding to the variant’s rise, UK researchers are growing the Delta variant for trials.
India’s DNA vaccine for COVID-19 gets emergency approval
India has granted emergency approval to the world's first DNA vaccine for COVID-19.
Pfizer’s shot is the first FDA-approved COVID-19 vaccine
Pfizer’s shot has become the first FDA-approved COVID-19 vaccine, making the transition from emergency use authorization on August 23.